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In this review of the evolution of diagnostic enzymology it would be only fitting, at the outset, to recall the very important part played by E. J. King. Throughout the formative years of this subject, from the late 1920's to the early 1960's, King's name appears frequently in the literature of diagnostic enzymology, and his contributions did much to enhance the value of enzyme tests as aids to diagnosis.
Comparisons between academic and clinical enzymology. Enzymology is an important branch of Biochemistry. As a discipline it had its origins 50-55 years ago. Prior to 1910, most work on enzymes had been empirical and of an applied nature but, in 1909, Sorensen described the preparation of several buffers and, soon after, Michaelis and Menten (1913) published their classical paper on the subject of enzyme kinetics.
With the recognition of the importance of closely controlling the many factors which influence enzyme-i-catalysed reactions, the science of enzymology began. These factors include pH, temperature, concentration of substrate and the presence of coenzymes, activators etc. At first, experiments with enzymes were mostly carried out with crude extracts from tissues. Later, with improvements in the techniques for purifying proteins, more and more enzymes were successfully purified and the reactions which they catalysed were studied as isolated systems. "Enzymes are found in nature in complex mixtures ... and in order to study a given enzyme properly it must be purified. In some cases ... it is possible by the use of sufficiently specific test methods to study enzymes while they are still in an impure state .... But in most cases some of the other enzymes present will interfere.... Indeed it is sometimes difficult, until the enzyme in question has been purified, to say exactly what reaction it catalyses" (Dixon and Webb, 1964) .
" Now that the importance of working with purified enzymes is so generally recognised, it seems strange that the early attempts at isolation met with criticism on the grounds that it was • unphysiological' to separate enzymes from the living cells and that it was important to work with intact tissues as far as possible. The tendency now is quite the reverse, namely, to regard with some suspicion work done with enzymes which have not been purified" (Dixon and Webb, 1964) .
These two quotations illustrate the viewpoint of the academic enzymologist. In general, the clinical enzymologist cannot hope to meet the exacting requirements of his more academic colleague, because the clinical enzymologist is for the most part interested in measurements of enzymatic activity in material obtained from individual living patients. This, of necessity, limits the amount of material available for study which, in turn, means that most enzyme studies of a clinical nature have been carried out with little or no further attempt at purification of the enzyme. Moreover, much clinical or diagnostic work with enzymes is carried out with blood, predominantly using serum or plasma, because clinical enzymologists are often interested in serial changes of enzymatic activity which may occur during the course of a disease, and blood is the only material which can readily be obtained for repeated study from a living patient. Blood and its components, e.g. serum, contain large numbers of enzymes and White (1958) , referring to academic enzymologists, said that "Enzymologists ... regarded blood as a contaminant of their tissue preparations and cursed it rather than assayed it". Blood has tended to be avoided by the academic enzymologist, but has been a most fruitful source of interesting information for the clinical enzymologist.
It would be wrong to go on stressing the differences in approach of the academic and the clinical enzymologist. Ultimately these differences reduce themselves to the degree of purity of the enzymatic preparations under assay. Both groups of workers are interested in the reactions catalysed by these various enzymes, and the requirements of quantitative enzymology and the shortcomings of some of the assay methods used in clinical enzymology are now fully recognized (Webb, 1961) . Even though the clinical enzymologist is still compelled to work predominantly with unpurified enzymes, he has profited from investigations on purified preparations; these have, in many instances, provided information about specific substrates or selective inhibitors, which have then been used to increase the specificity of enzyme assays performed for clinical purposes. In his turn, the clinical enzymologist has in recent years greatly stimulated the activities of his academic colleagues by focussing attention on the rapidly expanding subject of the isoenzymes.
Early work in diagnostic enzymology. The earliest applications of enzymatic assays, as aids to clinical diagnosis, were based on the estimation of digestive enzymes, notably amylase in urine (Wohlgemuth, 1908) and pepsin in gastric juice (Northrop, 1919) . The first extensive investigations of an enzymatic activity in serum for clinical purposes, were carried out by Kay (1929 Kay ( , 1930 on alkaline phosphatase; these studies included a comparison of levels of serum alkaline phosphatase activity from normal individuals with levels observed in patients suffering from a variety of diseases of bone. The assay method used by Kay (1930) was very slow, and one of King's earliest and most wellknown contributions to clinical enzymology was the part he played in the introduction of a more sensitive and much quicker method of measuring alkaline phosphatase activity in serum (King & Armstrong, 1934) .
During the 1930-1950 period biochemical research made notable advances, with the elucidation of many of the pathways of intermediary metabolism, in which most of the individual reactions are catalysed by enzymes. Clinical enzymology, as a subject, could not really profit from these studies until they had been extensively developed, and sensitive assay methods introduced, and few new enzymatic tests came into routine diagnostic use during this period. In the early years of clinical enzymology, the emphasis lay upon attempts to discover enzymes that were predominantly localised to one tissue of origin, and another example of the fruits of such work was the introduction of serum acid phosphatase determinations (Gutman & Gutman, 1938a, b) as an aid to the diagnosis of carcinoma of the prostate. Here again King made important contributions, which improved the specificity of the phenyl phosphate method (King & Armstrong, 1934 ) when applied to acid phosphatase determinations used for the investigation of prostatic disease (Abul-Fadl and King 1948 King , 1949 King and Jegatheesan, 1959) .
The recent expansion in the number of different serum enzyme assays which have been investigated and, in many cases, adopted as diagnostic tests stems from the work of Warburg and Christian (1943) . These authors had found that tumour tissues in rats contained abnormally large concentrations of various enzymes which catal-ysed reactions in the glycolytic pathway, and had found abnormally raised levels of some of these same enzymes in the serum from their experimental animals. They forecast that estimation of some of these enzymes in human serum might prove valuable in the diagnosis of malignant disease, and this prediction was in due course substantiated, e.g. for aldolase (Sibley & Lehninger, 1949) and for glucosephosphate isomerase (Bodansky, 1954) . In the last fifteen years the attention of clinical enzymologists has been directed to many other enzymes of importance in intermediary metabolism, in addition to the enzymes concerned in the glycolytic pathway. Many examples could be quoted, but attention will only be drawn here to the transaminases (LaDue, Wroblewski & Karmen, 1954) and to isocitrate dehydrogenase (W olfson and Williams-Ashman, 1957), important catalysts in aminoacid metabolism and in the citric acid cycle respectively. Much of this work has centred on the introduction of new assays of enzymatic activity in serum, as aids to the diagnosis of disease in particular organs, but the investigations on serum have been correlated with investigations of the properties of these same enzymes in individual tissues of the body.
So far, the various enzyme tests mentioned have been mainly concerned with the measurement of abnormal elevations of enzymatic activity produced in serum etc. as a result of disease. In some conditions abnormally low levels of enzymatic activity may be observed as a result of disease, e.g. serum cholinesterase and chronic liver disease (McArdle, 1940) . Development of these aspects of diagnostic enzymology, in which disease produces alterations in enzymatic activities in tissues, blood etc., had to wait upon the elucidation of the main pathways of intermediary metabolism.
The same holds true for another important aspect of diagnostic enzymology, namely the specific recognition of Inborn Errors of Metabolism. In this group of diseases, interest centres upon the recognition of enzymatic defects which cause disease, and in which the diagnosis can be specifically confirmed by showing that a particular enzyme is present in considerably decreased amounts, either in blood, serum, or in tissue preparations etc. Although Garrod's classical description of four Inborn Errors of Metabolism was published in 1908, few advances were made until after Beadle (1945) first clearly defined the concept of" one gene-one enzyme". Application of this concept, coupled with the growing The main ways in which disease can produce alterations in levels of enzymatic activity are summarised in Table I . Most of the tests used in diagnostic enzymology measure enzymatic activities in blood, and predominantly in serum or plasma.
understanding of the processes of intermediary metabolism, resulted in a rapid increase in the number of diseases recognised as being due to a specific inherited abnormality of metabolism. Enzymatic assays provide the definitive proof of each disease in this group, and are of great value in the investigation of relatives.
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The lesson to be drawn from this wealth of work on various enzymatic tests is that there are few, if any, examples of disease conditions in which a raised serum enzyme level can be regarded as specifically identifying the organ affected by the disease process. Even grossly elevated levels of serum amylase are not diagnostic of acute pancreatitis (e.g. McGowan & Wills, 1964) . When recommending the introduction of a new enzymatic test as an aid to diagnosis, therefore, it is insufficient to state that the test has proved positive in x per cent of a particular pathological condition, and details TABLE I I. Alteration in levels of enzymatic activity that are the causative factor in the disease process.
Inborn Errors of Metabolism, where detection of reduced levels of activity of the enzyme associated with the metabolic block provides definitive confirmation of the diagnosis.
2. Alteration in levels of enzymatic activity that are produced as a result of the disease process.
(a) Raised levels: e.g. release of intracellular enzymes into circulation, interference with elimination of enzymes after release into circulation. (b) Reduced levels: e.g. disease process interfering with synthesis of the enzyme.
Enzyme levels altered in disease
Developments in diagnostic enzymology since 1945. By 1945-1950, biochemical research had provided the basis for the various investigations which have since contributed to the rapid growth of diagnostic enzymology, but the very intensity of development of clinical enzymology in recent years has brought forth its own disadvantages. Different laboratories, working in parallel and investigating the same enzyme test as an aid to the diagnosis of particular clinical conditions, have not always agreed on the value of the test under investigation. for instance, leucine aminopeptidase was recommended for the investigation of patients suspected of having carcinoma of the pancreas (Rutenburg, Goldbarg & Pineda, 1958) but later workers found that the test was relatively unspecific (Harkness, Roper, Durant & Miller, 1960; Miller & Worsley, 1960) . Similarly, serum lactate dehydrogenase, when first investigated , was studied in normal individuals and in patients who had incurred a myocardial infarction, but numerous later publications have shown how relatively lacking in specificity was the finding of a raised serum lactate dehydrogenase; and the value of this particular enzyme in diagnosis has only become reestablished with the recognition of specific patterns of serum lactate dehydrogenase isoenzymes, evoked by disease affecting certain tissues. must be given of the number of times that the test has succeeded or failed in discriminating between the disease, for which its use is advocated, and those conditions which commonly give rise to difficulty in the clinical differential diagnosis. For its success, this type of investigation must depend on close cooperation between the clinical chemist and his clinical colleagues.
International Enzyme Commissions and Enzyme
Units. Another source of confusion which has arisen as a direct consequence of the upsurge of interest in the detection of altered enzyme levels as laboratory tests in diagnosis has been the multiplicity of units in which the results of investigations on one and the same enzyme may be expressed. King and Campbell (1961) gave a good example when they collected into one table some of the more commonly used methods of recording serum alkaline phosphatase activity. Another example of the multiplicity of units, and the consequent variation in published" normal ranges" of activity, is provided by the transaminases (Daly & Jordan, 1959 (King and Campbell, 1961; Webb, 1961; King and Moss, 1963) . Recommendations about nomenclature of enzymes and about the use of International Units for the expression of results were put forward.
Even with the results of enzymatic tests expressed in International Units, however, there is still room for variation in the normal ranges quoted by different authors for one and the same enzymatic activity, if only from purely technical considerations. This is because more than one substrate may have been used, or the temperature of incubation may have been different, or other variable factors may have affected the results, and in all cases it remains essential to describe accurately the conditions under which the measurements of enzymatic activity have been made. Consideration of alkaline phosphatase assays provides a simple example (King and Campbell, 1961) and use of International Units for expressing results of enzyme assays will not necessarily reduce the number of different •• normal ranges" appearing in the literature. It is too much to hope, therefore, that expression of results in International Units will put an end to attempts artifically to relate findings obtained by one technique with findings obtained by another completely different method. Transaminase units, for instance, were defined by Karmen (1955) in terms of initial reaction rates measured by a spectrophotometric technique performed at room temperature. Later, when Reitman and Frankel (1957) introduced their colorimetric method for determining transaminase levels, they measured the percentage conversion of substrate in a definite time at 40°, and related their colorimetric measurements to the results obtained by the method of Karmen (1955) , corrected to 25°. The conditions adopted by Reitman and Frankel (1957) , however, were not such as to constitute measurements of initial reaction rates, and Thiers and Vallee (1958) pointed out that the kinetics of one enzyme system cannot be applied safely to another system with the same activity. However, it is confusing to have large numbers of .. normal ranges" quoted for each enzymatic activity, and Reitman and Frankel (1957) were justified in their attempt to correlate their colorimetric assay with the earlier spectrophotometric procedure. Widespread adoption of International Units will not greatly reduce the number of times that individual enzymatic assays are reported with differing" normal ranges ", because of differences in conditions of assay, so comparisons between different techniques, such as the one carried out by Reitman and Frankel (1957) , will probably continue to be published even though the methods compared may have widely different kinetics.
It would undoubtedly be preferable if all enzyme determinations for clinical purposes were to be performed under conditions where zero order (or first order) kinetics obtained (Webb, 1961) , but this is not uniformly possible, particularly with measurements of enzymatic activity in serum, either because of the numbers of assays to be performed, or because of lack of sufficiently sensitive equipment, and it must be accepted that many of the. techniques used at present in clinical enzymology are inexact. Fortunately, this shortcoming does not detract greatly from the value of measurements of serum enzymatic activities made for diagnostic purposes, because in many instances disease of a particular tissue provokes gross alterations in these .levels. In other patients, where less marked alterations in serum enzyme levels have been produced by disease, serial assays of enzymatic activity can be particularly valuable; the patient in this case serves as his own control. As with other chemical parameters (e.g. blood urea, plasma electrolytes, serum proteins etc.) where there are wide" normal ranges ", each person probably has an individual normal value for each enzyme detectable in serum. Serial determinations of serum enzymatic activities can, in these patients, retrospectively provide assistance in making a diagnosis, even when the disease has been insufficiently severe to produce alterations beyond the" normal range" for the population as a whole. Although sometimes failing to meet the requirements for the exact study of enzyme kinetics, the conditions adopted for enzyme assays in clinical enzymology can, nevertheless, in these circumstances still provide much valuable information, deriving from comparisons between normal individuals and patients with various diseases. Table 2 ). The main objective of clinical enzymology in the period 1930-1950 would 2. Assay of enzymes which do not show a high degree of localisation to any tissue of origin but which may be released more readily by disease affecting one tissue rather than another. Alternatively, the localising ability of this group of enzyme assays can be increased by : (a) assaying two or more selected enzymes e.g. alanine and aspartate transaminases, aspartate} to differentiate between transaminase and isocitrate dehydrogenase cardiac and hepatic disease (b) interpretation of enzyme assays in conjunction with results of other laboratory investigations e.g. alanine transaminase and various" liver function tests".
The Specific Localization of Disease by Enzyme Tests (

Investigation of isoenzyme patterns.
Localization of disease by serum enzyme tests seem to have been the finding of enzymes specifically localised to one tissue, and the measurement of levels of these enzymes in serum where disease of the particular tissue was suspected. Tests based on measurements of such enzymes, it was argued, would have a relatively high degree of localising ability as far as recognising the tissue affected by disease, when interpreted together with the clinical findings.
With the introduction into diagnostic enzymology of measurements of enzymes concerned in intermediary metabolism, a new range of tests became available in which ability to indicate specifically the identity of the tissue affected by disease was less great. This apparent lack of specificity was due to the widespread occurrence of these enzymes. However, differences in the concentration of these enzymes in different tissues were observed, and many factors, some of them imperfectly understood, affect the relative ease with which these various enzymes are released into the circulation from different tissues. By suitable selection of single enzyme tests, or better still of combinations of enzyme tests, or by interpretation of enzyme tests in conjunction with results of other laboratory investigations, it was possible to improve the localising power of these newer enzymatic determinations.
Good examples of this use of combinations of enzyme tests are provided by determinations of both alanine and aspartate transaminase (Wroblewski 1958) or of both aspartate transaminase and isocitrate dehydrogenase (Sterkel, Spencer, Wolfson and Williams-Ashman, 1958 ; Bell, Shaldon and Baron, 1962) in the recognition and differentiation of various diseases, particularly cardiac and hepatic disease. However, the most interesting development in recent years, and one which has contributed greatly to improving the specificity of tests used in diagnostic enzymology, has been the recognition that enzymes can occur in multiple forms.
The first report of the heterogeneity of serum lactate dehydrogenase was published by Vesell and Beam (1957) and, in the same year, Wieland & Pfleiderer (1957) demonstrated several distinct forms on electrophoresis of lactate dehydrogenase prepared from various tissues of the same species. In 1961, a conference on Multiple Molecular Forms of Enzymes was held by the New York Academy of Sciences (Wroblewski, 1961) and the subject has been recently reviewed by Wieland and Pfleiderer (1963) , who have both contributed so much to its development.
A new series of terms has been introduced to describe the different recognisable forms of enzymes which catalyse one and the same reaction. This terminology is still not standardised, and the following definitions may require modification:
(a) Heteroenzymes: Enzymes which have the same catalytic activity but which come from different species or from individuals with different genetic composition within the same species. e.g. Lactate dehydrogenase from different species. Different inherited types of cholinesterase (Kalow, 1959). (b) Isoenzymes : This term was first proposed, as" isozymes ", by Markert and Meller (1959) as referring to eIectrophoretically distinguishable enzymes with similar substrate specificities. In more general terms, isoenzymes are enzymes which can be detected in different organs, or even in the same organ or tissue, from one individual, and which catalyse the same reaction but which can be shown to be different by various means.
(c) Isoalloenzymes: Enzymes from the same source of origin, which catalyse the same reaction but in different ways. e.g. different cofactor requirements, for instance isocitrate dehydrogenases which require either NAD or NADP; these two dehydrogenases can both be isolated from yeast (Kornberg and Pricer, 1951) .
Many different enzymes have been shown to exist in multiple forms, and the demonstration of specific isoenzyme patterns in serum, occurring as a result of disease in a particular organ, has contributed greatly to the localising value of enzyme tests in the identification of organs affected by disease. Few examples of isoalloenzymes have been recognised so far but, when the exact mechanism of action of more of the isoenzymes has been elucidated, it may be found that some belong correctly to the group of isoalloenzymes rather than to the group of isoenzymes (Wieland and Pfleiderer, 1963) .
The introduction into diagnostic enzymology of techniques which could demonstrate differences in serum isoenzyme patterns occurring in association with disease in various organs reopened the quest for enzyme or isoenzyme tests that could specifically identify tissues affected by disease. This has proved one of the most intensive and rewarding fields of research in clinical enzymology in recent years. Serum isoenzyme investigations can indicate that a particular tissue is affected by disease if there is a characteristic pattern of the isoenzyme in that tissue, and (Woodard, 1959) e-oxobutyrate, which is preferentially oxidised by fastest-moving (on electrophoresis) lactate dehydrogenase isoenzyme. (Rasalki and Wilkinson, 1960) 2. Use of specific inhibitors e.g. L( +) tartrate to inhibit prostatic acid phosphatase. (Fishman and Lerner, 1953) 3. Difference in stability between individual isoenzymes e.g. Heat stability of lactate dehydrogenase isoenzymes Stability to organic solvents of lactate dehydrogenase isoenzymes (Latner and Turner, 1963) (Thorne, 1960) 5. Differences in charge carried by individual isoenzymes e.g. starch gel electrophoresis-the classical direct method of demonstrating isoenzymes (Vesell and Beam, 1957 ) cellulose acetate electrophoresis (Barnett, 1962) . ion exchange chromatography-used in purification of e.g. malate dehydrogenase isoenzymes (Thorne, 1960) 6. Immunological identification of isoenzymes from different tissues e.g. alkaline phosphatase (Schlamowitz and Bodansky, 1959) amylase (McGeachin and Reynolds, 1959) Techniques used for demonstration of isoenzymes (Examples mainly drawn from Clinical Enzymology) if this pattern is reflected in serum as a result of disease affecting the tissue; such tests can differentiate between disease in this tissue and disease in another tissue, which might give rise to very similar symptoms and signs, if there are sufficient differences between the isoenzyme content of the two tissues and in the patterns produced in serum as a result of disease.
Many different techniques can now be employed to demonstrate isoenzymes. (Table 3. ) With plasma acid phosphatase, the prostatic component can be measured by using sodium -glycerophosphate as substrate (Woodard, 1954) , and the specificity of the assay still further improved by using platelet-poor plasma (Zucker and Borrelli, 1958) , or phenyl phosphate can be used as substrate in conjunction with L-tartrate as a specific inhibitor (Abul-Fadl and King, 1949; Fishman and Lerner, 1953) , and the possible existence of different molecular forms of prostatic acid phosphatase has been demonstrated by starch gel-electrophoresis. (Sur, Moss and King, 1962.) Some of the techniques listed in Table 3 have found application in routine diagnostic enzymology. Apart from the example of acid phosphatase, for instance, there has been the introduction of «-oxobutyrate (Rosalki and Wilkinson, 1960) for the differentiation of the isoenzyme patterns of lactate dehydrogenase in serum by means of differences in the substrate specificities of the individual isoenzymes. This is a less laborious technique than electrophoretic separation (Elliott, Jepson and Wilkinson, 1962) , and an alternative procedure depends on the relative thermostability of the fast-moving lactate dehydrogenase isoenzyme .
Principal applications of diagnostic enzymology at present. Although the main emphasis of this preceding discussion has been on serum enzyme patterns, or closely related topics, it should be stressed that measurements of enzyme levels have been made in many other types of specimens, and these measurements provide useful information in diagnostic enzymology. The range of specimens which can be examined is summarised in Table 4 , and isoenzyme studies have been extended to include some of these other materials, in addition to studies on isoenzymes in tissues and in blood.
Enzyme tests have come, therefore, to play an important part in the present-day work of the clinical chemistry laboratory. and Table 5 Early detection of cervical carcinoma by assay of phosphogluconate dehydrogenase activity (Bonham, 1964) Examples of specimens which can be examined in diagnostic enzymology 2. Aid to differential diagnosis-the commonest use ofenzymatic tests employed for diagnostic purposes.
3. Following course of a disease, and assessing the results of therapy.
4. Estimating prognosis-inexact assessment provided at present, except with gross alterations from normal levels of activity.
5. Screening apparently normal individuals, or patients on treatment e.g, (a) detection of carriers among relatives of patients with inherited metabolic disease (b) screening of potential blood-donors for unsuspected previous hepatitis (c) early detection of adverse reactions in psychiatric patients receiving potentially hepatotoxic drugs 6. Enzymes used as analytical tools for the specific estimation of their substrates e.g. glucose oxidase, urate oxidase etc.
Main purposes for which diagnostic enzymology is used classifies the main headings into which information obtained from enzymatic tests can be subdivided. Leaving aside the use of enzymes as analytical tools, the other categories list the variety of diagnostic information which can be provided by enzymatic tests. Because of this multiplicity of valuable information, these tests are requested frequently by clinicians for one reason or another, and it is fortunate, therefore, that improvements in instruments and automation have come to the aid of the chemical laboratory. Although many of the enzymatic assays commonly requested can be performed by relatively simple techniques, these manual methods nevertheless require close attention to details, and accuracy is liable to suffer when they have to be carried out in large numbers. Several enzymatic assays have now been modified into automatic or semi-automatic procedures, with improvements in accuracy and speed of handling for large numbers of samples. (Schwartz and Bodansky, 1963.) Future developments in diagnostic enzymology. In a review such as this it is customary to include some speculation about anticipated future trends. These are set out in Table 6 , and can be broadly summarised into (1) consolidation and development of existing activities, and (2) new areas of development. The principal interest in recent years has centred around isoenzymes, and much of the mass of information which has already accumulated will undoubtedly require some confirmation and consolidation. According to Table 6 , it is forecast that isoenzymes will continue to feature prominently in the development of diagnostic enzymology, and another subject which willcommandmuch attention is the elucidation of the various factors which influence the release of enzymes from inside cells, and which control the elimination of these enzymes after their release.
Diagnostic enzymology is one of the most actively developing areas of clinical chemistry, and clinicians will find enzyme tests more and more valuable to them in the investigation and management of their patients. With all the emphasis once more being laid on the recognition of enzyme or isoenzyme patterns specific for disease conditions affecting particular tissues, it is only prudent to stress the need for collaboration between clinicians and biochemists. Even with the most specific enzyme assays at his command, the biochemist cannot state authoritatively that a particular tissue is the primary site of a disease process. Only the clinician can be certain, for instance, that the patient has or has not had a rectal examination shortly before blood was collected for acid phosphatase determinations, and only the clinician has all the information on which to judge whether a patient has developed congestive cardiac failure as a complication of myocardial infarction. Secondary changes in other tissues, resulting from the deranged function of the tissue primarily affected 
Consolidation and development of existing activities
(a) standardisation of terminology-i-especially in relation to isoenzymes. (b) greater use of recording spectrophotometers, twin-channel Auto-Analyzers,* etc. t9 improve methods of assay, and allow easier handling of increasing workloads. (c) demonstration that multiple molecular forms of enzymes are the rule rather than the exception. (d) improvements in the quantitative fractionation of isoenzymes, and introduction of more assays based on properties of individual isoenzymes for measurement of selected components. (e) greater ability to detect minor variations in isoenzyme patterns, and to detect illness at an earlier stage in individuals. (f) establishment of the correct place of individual enzyme tests, or combinations of tests in the investigation of particular diagnostic problems. (g) greater use of enzymes as analytical tools.
Anticipated areas of new development
(a) evaluation and introduction of new enzymatic and isoenzyme tests not previously recognised as having potential value in diagnosis. (b) elucidation of the many factors which influence the release of intracellular enzymes into the circulation, and which control the subsequent elimination of these enzymes from the circulation. With clarification of these factors, enzyme assays should be able to provide information of value in prognosis. (c) development of assays for the specific measurement of individual isoenzymes, probably based on immunological procedures. This will require the successful purification of individual isoenzymes and preparation of specific antisera, but may well fail to provide a specific procedure for each isoenzyme because of probable close similarities between some isoenzymes. (d) elucidation of factors controlling the synthesis of the various isoenzymes, and clarification of the relationship between individual isoenzymes. (e) purification and structural studies on isoenzymes, and experiments to convert one isoenzyme into another by chemical or other means. (f) experiments on the structure of active centres in isoenzymes.
*Technicon Instruments Company Limited.
Future trends in diagnostic enzymology by disease, can greatly modify the interpretation of the results of enzyme tests and isoenzyme studies.
King fully appreciated the many ways in which diagnostic enzymology was developing, and his was one of the first laboratories of chemical pathology in the United Kingdom to have a sub-section particularly devoted to research on enzymes and isoenzymes, under the long-term charge of a member of his staff. He himself contributed significantly to each of the various aspects of this developing subject of diagnostic enzymology which have been mentioned in the present review.
Summary
The development of diagnostic enzymology is reviewed, and the contribution of enzyme and isoenzyme tests as aids to diagnosis and management of patients have been summarised. Some lines of possible future development in diagnostic enzymology are outlined.
